Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (296)
- COVID-19 (160)
- Compliance and enforcement (106)
- Safety monitoring and information (100)
- Legislation (81)
- Vaping hub (59)
- Manufacturing (58)
- Import and export (42)
- Labelling and packaging (41)
- Medicinal cannabis hub (29)
- Scheduling (national classification system) (24)
- Sunscreens (20)
- Weight loss products (18)
- Peptide products (11)
- Shortages and supply disruptions (10)
- Committees and advisory bodies (8)
- Cosmetics (6)
- Clinical trials (5)
- Unique Device Identification (UDI) hub (5)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1213 result(s) found, displaying 301 to 325
-
Media releasesThe Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024 will take effect on 1 July 2024, following passage through the Australian Parliament.
-
Media releasesTGA has issued 35 infringement notices totalling $627,252 to 6 businesses and 2 individuals for the alleged unlawful advertising of medicinal cannabis on their websites and social media platforms.
-
News articlesFind out about regulatory changes to a range of medical devices and application audit requirements.
-
News articlesPrescription lenses for refractive correction are now exempt from ARTG inclusion before supply in Australia, clarifying regulatory requirements.
-
Media releasesTGA has commenced proceedings in the Federal Court of Australia against Key Promotional Products Pty Ltd, and an individual, for allegedly importing and supplying unapproved rapid antigen test kits
-
Media releasesAmendments to the Therapeutic Goods Regulations 1990 (Schedule 5, item 6) have been made resulting in compounded GLP-1 RA products no longer being able to be compounded by pharmacists and supplied to patients.
-
News articlesThe Bill is part of reforms to prevent and reduce the use of vapes in Australia, unless clinically appropriate for stopping smoking or the management of nicotine dependence.
-
News articlesAnnex 16 will apply to therapeutic goods manufactured from 3 September 2024. Find out about the transition period.
-
Regulatory decision noticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024, which commenced on 14 June 2024.
-
Regulatory decision noticesThis instrument is the Therapeutic Goods (Poisons Standard) (Benzylpenicillin—Seqirus) Approval 2024.
-
News articlesWe are reviewing the safety information supporting notifications of the highest-risk medical devices used in first-in-human clinical trials. Find out how the changes we have implemented impact you as a sponsor.
-
Media releasesThe director of Elite Labs Pty Ltd was sentenced to 2 years imprisonment for his role in the unlawful manufacture, supply, advertising and export of performance and image enhancing therapeutic goods.
-
BlogMonitoring the safety of therapeutic goods is a key TGA role, and we depend on people reporting any side effects or issues.
-
BlogSome online health clinics are advertising and selling compounded medicines. However, it is important to know that compounded products are not identical to TGA approved products.
-
Media releasesAn infringement notice of $18,780 has been issued to Myers Pharmacy Pty Ltd for the alleged unlawful advertising of Ozempic, a prescription-only medicine.
-
Safety updatesThe Product Information (PI) documents for antidepressants have been updated with warnings about sexual dysfunction continuing in some patients, after they stop using the medicines.
-
Media releasesInfringement notices totalling $171,972 have been issued to Better Leaf Pty Ltd, and an individual, for the alleged unlawful advertising of medicinal cannabis on its website and social media.
-
Media releasesThe Dolphins National Rugby League club has worked with us, agreeing to remove Alternaleaf branding from its jerseys and on signages displayed at stadiums during its games.
-
Media releasesWe have issued 2 infringement notices totalling $37,560 to Global Medical Solutions Australia Pty Limited, trading as Radpharm Scientific Pty Ltd, for allegedly breaching conditions of its manufacturing licence
-
Media releasesVictoria-based nurse has been issued 2 infringement notices totalling $7,512 for allegedly importing unapproved prescription-only and cosmetic injectable products.
-
Media releasesAn individual based in Victoria has been fined $3,756 for the alleged unlawful importation of a peptide. They did not have approval to import the prescription-only medicine.
-
News articlesConsistent with recent EMA updates of acceptable intakes for established N-nitrosamines, the TGA has published updated acceptable intakes for nitrosamines in medicines.
-
Regulatory decision noticesVoluntary cancellation of AstraZeneca COVID-19 vaccine: Vaxzevria
-
Media releasesBe aware that cannabis oil or cannabis flower medicine coming from overseas, or here in Australia, both must comply with the quality standard. Products that don't, may be unsafe.
-
News articlesWe will adopt the 2021 Sunscreen Standard into therapeutic goods legislation. If you're a manufacturer or sponsor, find out what this means for you.